Global Formulation Development Outsourcing Market 2022-2028
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
According to Gen Consulting Company, the global formulation development outsourcing market is set to achieve an incremental growth of USD 8 billion, acelerating at a CAGR of almost 7.1% during the forecast period 2022-2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global formulation development outsourcing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the formulation development outsourcing industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the service, dosage form, application, end user, and region. The global market for formulation development outsourcing can be segmented By service formulation optimization, pre-formulation services. Formulation development outsourcing market is further segmented By dosage form: inhaled, injectable, oral, topical, others. Based on application, the formulation development outsourcing market is segmented into: cardiovascular, genetic disorders, infectious diseases, neurology, oncology, respiratory, others. On the basis of end user, the formulation development outsourcing market also can be divided into: government and academic institutes, pharmaceutical and biopharmaceutical companies. Formulation development outsourcing market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By service:
- formulation optimization
- pre-formulation services
By dosage form:
- inhaled
- injectable
- oral
- topical
- others
By applicationt:
- cardiovascular
- genetic disorders
- infectious diseases
- neurology
- oncology
- respiratory
- others
By end user:- government and academic institutes
- pharmaceutical and biopharmaceutical companies
By region:
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)
The report also provides a detailed analysis of several leading formulation development outsourcing market vendors that include Aizant Drug Research Solutions Private Limited, Biocon Limited (Syngene International Limited), Catalent Inc., Charles River Laboratories International Inc., Emergent BioSolutions Inc., Intertek Group plc, IRISYS LLC, Laboratory Corporation of America Holdings (LabCorp), Lonza Group AG, PCI Pharma Services, Inc. (PCI), Piramal Enterprises Ltd, Quotient Sciences Limited, Thermo Fisher Scientific Inc. (Patheon N.V.), among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global formulation development outsourcing market.
- To classify and forecast the global formulation development outsourcing market based on service, dosage form, application, end user, region.
- To identify drivers and challenges for the global formulation development outsourcing market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global formulation development outsourcing market.
- To identify and analyze the profile of leading players operating in the global formulation development outsourcing market.
Why Choose This Report
- Gain a reliable outlook of the global formulation development outsourcing market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global formulation development outsourcing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the formulation development outsourcing industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the service, dosage form, application, end user, and region. The global market for formulation development outsourcing can be segmented By service formulation optimization, pre-formulation services. Formulation development outsourcing market is further segmented By dosage form: inhaled, injectable, oral, topical, others. Based on application, the formulation development outsourcing market is segmented into: cardiovascular, genetic disorders, infectious diseases, neurology, oncology, respiratory, others. On the basis of end user, the formulation development outsourcing market also can be divided into: government and academic institutes, pharmaceutical and biopharmaceutical companies. Formulation development outsourcing market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By service:
- formulation optimization
- pre-formulation services
By dosage form:
- inhaled
- injectable
- oral
- topical
- others
By applicationt:
- cardiovascular
- genetic disorders
- infectious diseases
- neurology
- oncology
- respiratory
- others
By end user:- government and academic institutes
- pharmaceutical and biopharmaceutical companies
By region:
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)
The report also provides a detailed analysis of several leading formulation development outsourcing market vendors that include Aizant Drug Research Solutions Private Limited, Biocon Limited (Syngene International Limited), Catalent Inc., Charles River Laboratories International Inc., Emergent BioSolutions Inc., Intertek Group plc, IRISYS LLC, Laboratory Corporation of America Holdings (LabCorp), Lonza Group AG, PCI Pharma Services, Inc. (PCI), Piramal Enterprises Ltd, Quotient Sciences Limited, Thermo Fisher Scientific Inc. (Patheon N.V.), among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global formulation development outsourcing market.
- To classify and forecast the global formulation development outsourcing market based on service, dosage form, application, end user, region.
- To identify drivers and challenges for the global formulation development outsourcing market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global formulation development outsourcing market.
- To identify and analyze the profile of leading players operating in the global formulation development outsourcing market.
Why Choose This Report
- Gain a reliable outlook of the global formulation development outsourcing market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY SERVICE
Formulation optimization
Pre-formulation services
PART 6. MARKET BREAKDOWN BY DOSAGE FORM
Inhaled
Injectable
Oral
Topical
Others
PART 7. MARKET BREAKDOWN BY APPLICATION
Cardiovascular
Genetic disorders
Infectious diseases
Neurology
Oncology
Respiratory
Others
PART 8. MARKET BREAKDOWN BY END USER
Government and academic institutes
Pharmaceutical and biopharmaceutical companies
PART 9. MARKET BREAKDOWN BY REGION
North America
Asia Pacific
Europe
Rest of the World (ROW)
PART 10. KEY COMPANIES
Aizant Drug Research Solutions Private Limited
Biocon Limited (Syngene International Limited)
Catalent Inc.
Charles River Laboratories International Inc.
Emergent BioSolutions Inc.
Intertek Group plc
IRISYS LLC
Laboratory Corporation of America Holdings (LabCorp)
Lonza Group AG
PCI Pharma Services, Inc. (PCI)
Piramal Enterprises Ltd
Quotient Sciences Limited
Thermo Fisher Scientific Inc. (Patheon N.V.)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY SERVICE
Formulation optimization
Pre-formulation services
PART 6. MARKET BREAKDOWN BY DOSAGE FORM
Inhaled
Injectable
Oral
Topical
Others
PART 7. MARKET BREAKDOWN BY APPLICATION
Cardiovascular
Genetic disorders
Infectious diseases
Neurology
Oncology
Respiratory
Others
PART 8. MARKET BREAKDOWN BY END USER
Government and academic institutes
Pharmaceutical and biopharmaceutical companies
PART 9. MARKET BREAKDOWN BY REGION
North America
Asia Pacific
Europe
Rest of the World (ROW)
PART 10. KEY COMPANIES
Aizant Drug Research Solutions Private Limited
Biocon Limited (Syngene International Limited)
Catalent Inc.
Charles River Laboratories International Inc.
Emergent BioSolutions Inc.
Intertek Group plc
IRISYS LLC
Laboratory Corporation of America Holdings (LabCorp)
Lonza Group AG
PCI Pharma Services, Inc. (PCI)
Piramal Enterprises Ltd
Quotient Sciences Limited
Thermo Fisher Scientific Inc. (Patheon N.V.)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
RELATED REPORTS
Global Natural Food Colors Market 2023
DescriptionNatural food colors are commonly incorporated ingredients that enhance food products visual appeal, a primary factor influencing consumer purchasing decisions. Vivid, attractive colors signal higher perceived value and instigate selection.
USD 3450 View ReportGlobal Frozen-Cooked Ready Meals Market 2023
DescriptionThe global frozen-cooked ready meals market is anticipated to expand at a healthy compound annual growth rate of 3.8% between 2023 and 2029. The market size is projected to increase
USD 1875 View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS